Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001387131-20-001050

Chief Strategy Officer sold 300,000 shares at $2.26 ($676,920)

  • Chief Strategy Officer acquired 300,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Krassan Mitchell Chief Strategy Officer 2020-02-03 Option exercise +105,703 $0.19 $19,809 105,703 D: show line 1 in the form
Krassan Mitchell Chief Strategy Officer 2020-02-03 Option exercise +194,297 $0.20 $39,578 300,000 D: show line 2 in the form
Krassan Mitchell Chief Strategy Officer 2020-02-03 Sale −300,000 $2.26 $676,920 0 D: show line 3 in the form
Open-market sales · 300,000 sh · avg $2.26 · $676,920

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Krassan Mitchell Chief Strategy Officer 2020-02-03 Option exercise · Non-Qualified Stock Option (right to buy) −105,703 0 D: show line 4 in the form
Krassan Mitchell Chief Strategy Officer 2020-02-03 Option exercise · Non-Qualified Stock Option (right to buy) −194,297 489,658 D: show line 5 in the form
Loading xslF345X03/krassan-form4_020320.xml…